Unicycive Therapeutics, Inc.
UNCY • NASDAQ
Unicycive Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shalabh K. Gupta, with a market cap of $137.3M.
CEOShalabh K. Gupta
Next Earnings
Upcoming earnings announcement for Unicycive Therapeutics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.38
Revenue Estimate
$14.3M
Earnings History
Past 12 earnings reports for Unicycive Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.82Est: -$0.46 | -78.3% | -Est: $590.9K | -100.0% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.46Est: -$0.55 | +16.4% | -Est: $265.6K | -100.0% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.52Est: -$0.70 | +25.7% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.05Est: -$0.07 | +28.6% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.26Est: -$0.07 | -271.4% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.05Est: -$0.15 | +66.7% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.15Est: -$0.19 | +21.1% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.61Est: -$0.15 | -306.7% | $675.0K | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.22Est: -$0.17 | -29.4% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.37Est: -$0.12 | -208.3% | $951.0K | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.29Est: -$0.34 | +14.7% | - | — | 10-Q |
| May 16, 2023 | Q1 2023 | -$0.29Est: -$0.37 | +21.6% | -Est: $370.0K | -100.0% | — |